CRASH: Should you buy shares of Healthscope Ltd?

Healthscope Ltd (ASX:HSO) shares have plummeted 23% since Friday.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of Healthscope Ltd (ASX: HSO) have been absolutely hammered recently. Although they have managed to regain 1.3% today (trading at $2.27 per share) they are still an agonising 22.5% below their closing price from Thursday last week.

What happened to Healthscope?

It was less than one month ago that Healthscope's shares were trading at an all-time high of $3.17, up from an offer price of $2.10 when the group listed its shares on the ASX in July 2014. At that price, they were trading on a multiple of more than 30x trailing earnings, reflecting the strong growth that had been baked into the group's share price.

Unfortunately, Healthscope gave investors reason to doubt its growth prospects when it held its Annual General Meeting late last week. In an update to the market, it said it had experienced slower-than-expected revenue growth in its Hospitals division during the first quarter of financial year 2017.

It noted: "Various data points across the industry tell us that the average rate of hospital volume growth generally has slowed. We have seen this impact a number of our hospitals resulting in increased variability in volumes and case mix month to month in the first quarter and particularly in September. Management focus continues to be on driving revenue growth and disciplined cost control."

It also said that earnings growth (based on EBITDA, or earnings before interest, tax, depreciation and amortisation) from its Hospitals division would be flat year-on-year if the trend for the first quarter was to continue.

Notably, shares of Healthscope rival, Ramsay Health Care Limited (ASX: RHC), have also shed more than 9% over the same period, likely reflecting investors' concerns that Healthscope's woes are not company-specific and, instead, apply to the industry as a whole.

Should you buy?

Healthscope was looking pricey when it traded above $3 per share, but now that it has cooled down it's worthy of a closer look. That said, the shares are still trading on a price to earnings ratio of almost 22x last year's earnings, which isn't a bargain if slower growth does become more commonplace for the private hospital operator. This is something prospective investors should bear in mind.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »